• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过表面 PEG 配对克服纳米颗粒介导的补体激活。

Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG Pairing.

机构信息

Laboratory of Nanotechnology for Precision Medicine, Fondazione Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genoa, Italy.

Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Via dei Vestini 31, I-66100 Chieti, Italy.

出版信息

Nano Lett. 2020 Jun 10;20(6):4312-4321. doi: 10.1021/acs.nanolett.0c01011. Epub 2020 May 27.

DOI:10.1021/acs.nanolett.0c01011
PMID:32259451
Abstract

Many PEGylated nanoparticles activate the complement system, which is an integral component of innate immunity. This is of concern as uncontrolled complement activation is potentially detrimental and contributes to disease pathogenesis. Here, it is demonstrated that, in contrast to carboxyPEG-stabilized poly(lactic--glycolic acid) nanoparticles, surface camouflaging with appropriate combinations and proportions of carboxyPEG and methoxyPEG can largely suppress nanoparticle-mediated complement activation through the lectin pathway. This is attributed to the ability of the short, rigid methoxyPEG chains to laterally compress carboxyPEG molecules to become more stretched and assume an extended, random coil configuration. As supported by coarse-grained molecular dynamics simulations, these conformational attributes minimize statistical protein binding/intercalation, thereby affecting sequential dynamic processes in complement convertase assembly. Furthermore, PEG pairing has no additional effect on nanoparticle longevity in the blood and macrophage uptake. PEG pairing significantly overcomes nanoparticle-mediated complement activation without the need for surface functionalization with complement inhibitors.

摘要

许多聚乙二醇化纳米颗粒会激活补体系统,补体系统是先天免疫系统的一个组成部分。这令人担忧,因为不受控制的补体激活可能是有害的,并导致疾病发病机制。在这里,与羧基聚乙二醇稳定的聚(乳酸-乙醇酸)纳米颗粒相反,通过适当组合和比例的羧基聚乙二醇和甲氧基聚乙二醇进行表面伪装,可以通过凝集素途径在很大程度上抑制纳米颗粒介导的补体激活。这归因于短而刚性的甲氧基聚乙二醇链能够横向压缩羧基聚乙二醇分子,使其变得更加伸展,并呈现出伸展的随机卷曲构象。粗粒度分子动力学模拟支持了这一观点,这些构象特征最大限度地减少了蛋白质的统计结合/插入,从而影响补体转化酶组装的顺序动态过程。此外,PEG 配对对纳米颗粒在血液中的寿命和巨噬细胞摄取没有额外的影响。PEG 配对显著克服了纳米颗粒介导的补体激活,而不需要用补体抑制剂对表面进行功能化。

相似文献

1
Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG Pairing.通过表面 PEG 配对克服纳米颗粒介导的补体激活。
Nano Lett. 2020 Jun 10;20(6):4312-4321. doi: 10.1021/acs.nanolett.0c01011. Epub 2020 May 27.
2
Engineering PEGylated Polyester Nanoparticles to Reduce Complement-Mediated Infusion Reaction.工程化聚乙二醇化聚酯纳米粒子以减少补体介导的输注反应。
Bioconjug Chem. 2021 Oct 20;32(10):2154-2166. doi: 10.1021/acs.bioconjchem.1c00339. Epub 2021 Sep 9.
3
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.不同的聚合物结构在纳米球-血清界面调节补体激活途径的转换:对隐形纳米颗粒工程的启示。
ACS Nano. 2010 Nov 23;4(11):6629-38. doi: 10.1021/nn101990a. Epub 2010 Oct 28.
4
Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles.聚乙二醇(PEG)链对 PCL 生物医学纳米粒子补体激活抑制和体内寿命延长的影响。
Biomed Microdevices. 2009 Dec;11(6):1187-94. doi: 10.1007/s10544-009-9336-2.
5
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo.抗聚乙二醇抗体改变了纳米颗粒上沉积的蛋白质冠,以及调节其体内命运的生理途径。
J Control Release. 2018 Oct 10;287:121-131. doi: 10.1016/j.jconrel.2018.08.022. Epub 2018 Aug 21.
6
In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.载 IFN-α 和聚乙二醇化 IFN-α 的聚(丙交酯-乙交酯)和聚乙二醇化聚(丙交酯-乙交酯)纳米粒的体外 IFN-α 释放。
Nanomedicine (Lond). 2016 Aug;11(16):2029-34. doi: 10.2217/nnm-2016-0058. Epub 2016 Jul 27.
7
Self-assembly of core-polyethylene glycol-lipid shell (CPLS) nanoparticles and their potential as drug delivery vehicles.核-聚乙二醇-脂质壳(CPLS)纳米粒子的自组装及其作为药物传递载体的潜力。
Nanoscale. 2016 Aug 21;8(31):14821-35. doi: 10.1039/c6nr04134e. Epub 2016 Jul 25.
8
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.聚乙二醇化纳米颗粒与淀粉样β肽结合并改变其构象:用于阿尔茨海默病的功能性纳米药物的工程设计。
ACS Nano. 2012 Jul 24;6(7):5897-908. doi: 10.1021/nn300489k. Epub 2012 Jun 19.
9
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake.聚乙二醇化脂质纳米囊泡与补体系统激活及巨噬细胞摄取的评估。
J Biomed Mater Res A. 2006 Sep 1;78(3):620-8. doi: 10.1002/jbm.a.30711.
10
Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.叶酸共轭两亲性聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒对顺铂和紫杉醇共递送的血液相容性:对非小细胞肺癌的治疗效果
Tumour Biol. 2016 Jun;37(6):7809-21. doi: 10.1007/s13277-015-4634-1. Epub 2015 Dec 22.

引用本文的文献

1
Nano drug delivery system based on natural cells and derivatives for ischemic stroke treatment.基于天然细胞及其衍生物的纳米药物递送系统用于缺血性中风治疗。
Chin Med J (Engl). 2025 Aug 20;138(16):1945-1960. doi: 10.1097/CM9.0000000000003685. Epub 2025 Jul 4.
2
Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.使用补体途径抑制剂增强纳米药物在多个物种中的免疫相容性和血液相容性。
Sci Adv. 2025 Jul 11;11(28):eadw1731. doi: 10.1126/sciadv.adw1731. Epub 2025 Jul 9.
3
Implications of Anaphylaxis Following mRNA-LNP Vaccines: It Is Urgent to Eliminate PEG and Find Alternatives.
mRNA-LNP疫苗接种后发生过敏反应的影响:消除聚乙二醇并寻找替代物刻不容缓。
Pharmaceutics. 2025 Jun 19;17(6):798. doi: 10.3390/pharmaceutics17060798.
4
Lipid-Coated Ag@MnO Core-Shell Nanoparticles for Co-Delivery of Survivin siRNA in Breast Tumor Therapy.用于乳腺癌治疗中Survivin siRNA共递送的脂质包被Ag@MnO核壳纳米颗粒
Int J Nanomedicine. 2025 May 22;20:6515-6531. doi: 10.2147/IJN.S510514. eCollection 2025.
5
Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase.脂质液晶纳米颗粒作为容纳敏感膜蛋白的合适平台:监测HMG-CoA还原酶的活性
J Nanobiotechnology. 2025 May 7;23(1):334. doi: 10.1186/s12951-025-03370-6.
6
PEGylation technology: addressing concerns, moving forward.聚乙二醇化技术:解决问题,向前迈进。
Drug Deliv. 2025 Dec;32(1):2494775. doi: 10.1080/10717544.2025.2494775. Epub 2025 Apr 23.
7
Macrophage membrane coated discoidal polymeric particles for evading phagocytosis.用于逃避吞噬作用的巨噬细胞膜包被盘状聚合物颗粒
Biomed Eng Lett. 2024 Jun 12;14(5):1113-1124. doi: 10.1007/s13534-024-00396-x. eCollection 2024 Sep.
8
Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles.揭示不同脂质体制剂对血浆蛋白冠层组成的影响可能会为纳米颗粒的靶向能力提供线索。
Nanoscale Adv. 2024 Jul 2;6(17):4434-4449. doi: 10.1039/d4na00345d. eCollection 2024 Aug 20.
9
Albumin Nanoparticle-Based Drug Delivery Systems.白蛋白纳米粒药物传递系统。
Int J Nanomedicine. 2024 Jul 10;19:6945-6980. doi: 10.2147/IJN.S467876. eCollection 2024.
10
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.脂质纳米粒在结直肠癌治疗中的研究进展。
Int J Nanomedicine. 2024 Jul 3;19:6693-6715. doi: 10.2147/IJN.S466490. eCollection 2024.